1. 2020 shaping up to be another strong year for FDA drug approvals — Medical aesthetics procedures skyrocket post-lockdown; pharma rolls out campaigns — New atlas of the human heart could guide personalized medicine in cardiology — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice
  1. anonymous

    anonymous Guest

    This company is a joke. They should be sold and don't stand a chance of growing.
    Mgt is clueless. I can't stand working here. No respect for this bozo in CO.
     
  2. anonymous

    anonymous Guest

    Heard they are mailing results to patients. That gimmick is old. Doctors question who is opening the mail. Did it get delivered to the neighbors, jealous husband open it?
     
  3. anonymous

    anonymous Guest

    no chance of selling. we don't have market share anywhere. waiting for us to tc/pc with derm clients next.
     
  4. anonymous

    anonymous Guest

    we suck. pathologists are incompetent
     
  5. anonymous

    anonymous Guest

    The manager in CO. is a joke. The owners are clueless about the industry. The business plan spells "for Sale"
     
  6. anonymous

    anonymous Guest

    who is leading this company? clueless and no growth.............all effort is put into partnerships with expensive testing...........
     
  7. anonymous

    anonymous Guest


    the company needs to sell
     
  8. anonymous

    anonymous Guest

    Losing market share in Colorado............
     
  9. anonymous

    anonymous Guest

    mgmt. is a complete joke!